ArticleAmerican journal of translational research2026
Balloon dilatation combined with thrombectomy reduces myocardial injury in massive pulmonary embolism.
Article in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo investigate the alterations in myocardial injury markers following balloon dilatation combined with thrombectomy in patients with massive pulmonary embolism (MPE).
methodsA retrospective study was conducted in 90 patients diagnosed with MPE. Clinical efficacy, Miller scores, pulmonary artery pressure (PAP), pulmonary artery diameter (PAD), and levels of myocardial injury markers were evaluated and compared between the combined treatment group (balloon dilatation plus thrombectomy) and the basic treatment group (basic therapy alone).
resultsCompared to the basic treatment group, the combined treatment group exhibited significantly improved clinical efficacy, including higher rates of complete response, marked response, and overall response. Hemodynamic and cardiac function indices were significantly improved, as evidenced by lower post-treatment Miller score, PAP, PAD, and right ventricular/left ventricular (RV/LV) ratios. Myocardial injury and inflammation-related indicators, including myoglobin (MYO), troponin T (TnT), creatine kinase (CK), and fibrinogen (FIB) were significantly reduced at specific time points in the combined treatment group. Furthermore, significant correlations were identified between injury markers and arterial blood gas indices: CK at 24 hours was inversely correlated with arterial partial pressure of carbon dioxide (PaCO
conclusionBalloon dilation combined with thrombectomy for the treatment of MPE can significantly reduce myocardial injury and inflammation-related indicators, thereby markedly improving clinical outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.